Apodi Limited’s Post

Did you know? 🚨 NHS waiting lists have nearly tripled over the past decade, skyrocketing to a staggering 7.4 million for patients in England alone! 😱 This has caused major challenges in driving patient access to medicines for pharmaceutical companies across the UK. 💊 Apodi has explored these issues, offering invaluable insights on how pharmaceutical companies can support the NHS in tackling these waiting lists, while ensuring better access to essential medications. 💪 Curious about our findings and how we're making a difference? Dive into our case study for a closer look at how collaboration can pave the way for better healthcare outcomes: https://lnkd.in/edpKraa9 📈💡 #Healthcare #PatientAccess #PatientCare #PatientExperience #PatientCentricity #PatientSupport #Homecare #PSP #NHS 

Did you know? 🚨 NHS waiting lists have nearly tripled over the past decade, skyrocketing to a staggering 7.4 million for patients in England alone! 😱 This has caused major challenges in driving patient access to medicines for pharmaceutical companies across the UK. 💊 Apodi has explored these issues, offering invaluable insights on how pharmaceutical companies can support the NHS in tackling these waiting lists, while ensuring better access to essential medications. 💪 Curious about our findings and how we're making a difference? Dive into our case study for a closer look at how collaboration can pave the way for better healthcare outcomes: https://lnkd.in/edpKraa9 📈💡 #Healthcare #PatientAccess #PatientCare #PatientExperience #PatientCentricity #PatientSupport #Homecare #PSP #NHS

Patient Solution with Celaxis Healthcare * **Patient Education and Support:** CSMOs provide resources and programs to educate patients about their conditions and empower them to manage their health effectively. * **Personalized Patient Experiences:** They leverage technology and data to tailor patient interactions and support based on individual needs and preferences. * **Improved Access to Therapies:** CSMOs connect pharmaceutical companies with healthcare providers, ensuring that patients have access to innovative and effective treatments. * **Enhanced Prescribing Practices:** CSMOs collaborate with medical professionals to optimize prescribing practices, leading to better patient outcomes. * **Bridge Between Pharma and Healthcare:** They facilitate communication and collaboration between pharmaceutical companies and healthcare providers, ensuring that patient needs are met. #RuralMarketing #PatientSolution #patientcare #patientadvocacy #CSMO #ContractSalesAndMarketing #Celaxis #CelaxisHealthcare #pharmaceutical #pharmasolutions #pharmaceuticalindustry

The recent collaboration between The Innovation and Value Initiative (IVI), Alliance for Aging Research, Leavitt Partners, and National Pharmaceutical Council has shed light on critical #healthequity issues and #patientengagement within the Drug Price Negotiation Program (DPNP) context. Read at The Evidence Base® #drugpricing #medicare #inflationreductionact

This just in: We’ve updated our Guiding Practices for Patient-Centered Value Assessment! The Guiding Practices include 33 specific recommendations to ensure value assessments account for the full value pharmaceuticals provide to patients and society. Access the 2024 edition here: https://lnkd.in/eespYnVy

🚨 A House Oversight report finds that Pharmacy Benefit Managers (PBMs) prioritize higher-priced medicines when lower-cost options are available for patients - leading to higher costs for patients and the healthcare system. Combined with today's hearing on accountability and transparency for PBMs, this report marks a significant moment in time for drug manufacturers to illustrate how patients benefit from the medicines they develop. 💊 The pharmaceutical industry has an opportunity to lift patient stories to highlight the real-world personal impact of their products in the media, on social media, and through digital promotion. Patient stories resonate emotionally with audiences, fostering empathy and understanding while emphasizing the significance of innovation in healthcare. By sharing authentic narratives, patients can effectively convey the benefits of treatments. Companies should highlight medical advancements and demonstrate their commitment to these patients. https://lnkd.in/gnDm2wUn

Attempts to curb the cost of innovative #medicines to the taxpayer must not dissuade #pharmaceutical companies from investing in their development and commercialisation in the UK, says our #medicines and #regulatory expert Gareth Morgan in this Out-Law News article 👇 . #lifesciences #pharma #pinsentmasons

With over 385,000 NPs across the U.S., it's clear why targeting NPs is crucial for pharmaceutical companies. Their growing influence in healthcare, from prescribing authority to roles as primary care providers and specialists, makes NPs key players in patient care decisions. Don't overlook the power of NPs in transforming patient outcomes, its easier than ever to engage NPs with Novem! #Novem #NursePractitioners #PharmaMarketing

Check out my latest column on The Evidence Base® for recent developments in the intersection of Medicare drug price negotiation and value assessment. Read here >>> https://lnkd.in/etEAr4Z5 #inflationreductionact #hta #valueassessment #qaly

Catch up on our regular column - Value Viewpoint - where Kimberly Westrich (Chief Strategy Officer, National Pharmaceutical Council) shares highlights on US healthcare value and access from May and June 2024. Read at The Evidence Base® #heor #healtheconomics #marketaccess #medicalaffairs #hta #healthtechnologyassessment #healthdata #healthpolicy #valueassessment #inflationreductionact #ISPORAnnual